Literature DB >> 23476019

Coordinate changes in histone modifications, mRNA levels, and metabolite profiles in clonal INS-1 832/13 β-cells accompany functional adaptations to lipotoxicity.

Siri Malmgren1, Peter Spégel, Anders P H Danielsson, Cecilia L Nagorny, Lotta E Andersson, Marloes Dekker Nitert, Martin Ridderstråle, Hindrik Mulder, Charlotte Ling.   

Abstract

Lipotoxicity is a presumed pathogenetic process whereby elevated circulating and stored lipids in type 2 diabetes cause pancreatic β-cell failure. To resolve the underlying molecular mechanisms, we exposed clonal INS-1 832/13 β-cells to palmitate for 48 h. We observed elevated basal insulin secretion but impaired glucose-stimulated insulin secretion in palmitate-exposed cells. Glucose utilization was unchanged, palmitate oxidation was increased, and oxygen consumption was impaired. Halting exposure of the clonal INS-1 832/13 β-cells to palmitate largely recovered all of the lipid-induced functional changes. Metabolite profiling revealed profound but reversible increases in cellular lipids. Glucose-induced increases in tricarboxylic acid cycle intermediates were attenuated by exposure to palmitate. Analysis of gene expression by microarray showed increased expression of 982 genes and decreased expression of 1032 genes after exposure to palmitate. Increases were seen in pathways for steroid biosynthesis, cell cycle, fatty acid metabolism, DNA replication, and biosynthesis of unsaturated fatty acids; decreases occurred in the aminoacyl-tRNA synthesis pathway. The activity of histone-modifying enzymes and histone modifications of differentially expressed genes were reversibly altered upon exposure to palmitate. Thus, Insig1, Lss, Peci, Idi1, Hmgcs1, and Casr were subject to epigenetic regulation. Our analyses demonstrate that coordinate changes in histone modifications, mRNA levels, and metabolite profiles accompanied functional adaptations of clonal β-cells to lipotoxicity. It is highly likely that these changes are pathogenetic, accounting for loss of glucose responsiveness and perturbed insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23476019      PMCID: PMC3636884          DOI: 10.1074/jbc.M112.422527

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

3.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

4.  Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function.

Authors:  Anna K Busch; Damien Cordery; Gareth S Denyer; Trevor J Biden
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

Review 5.  Fatty acid signaling in the beta-cell and insulin secretion.

Authors:  Christopher J Nolan; Murthy S R Madiraju; Viviane Delghingaro-Augusto; Marie-Line Peyot; Marc Prentki
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

6.  Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue.

Authors:  Anne Boucher; Danhong Lu; Shawn C Burgess; Sabine Telemaque-Potts; Mette V Jensen; Hindrik Mulder; May-Yun Wang; Roger H Unger; A Dean Sherry; Christopher B Newgard
Journal:  J Biol Chem       Date:  2004-04-07       Impact factor: 5.157

7.  Silencing of the mitochondrial NADH shuttle component aspartate-glutamate carrier AGC1/Aralar1 in INS-1E cells and rat islets.

Authors:  Marina Casimir; Blanca Rubi; Francesca Frigerio; Gaelle Chaffard; Pierre Maechler
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

8.  Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity.

Authors:  Mayumi Ishikawa; Yuko Iwasaki; Shigeru Yatoh; Toyonori Kato; Shin Kumadaki; Noriyuki Inoue; Takashi Yamamoto; Takashi Matsuzaka; Yoshimi Nakagawa; Naoya Yahagi; Kazuto Kobayashi; Akimitsu Takahashi; Nobuhiro Yamada; Hitoshi Shimano
Journal:  J Lipid Res       Date:  2008-08-05       Impact factor: 5.922

9.  Why expression of some genes is disallowed in beta-cells.

Authors:  Roel Quintens; Nico Hendrickx; Katleen Lemaire; Frans Schuit
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

10.  Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets.

Authors:  B T Yang; T A Dayeh; C L Kirkpatrick; J Taneera; R Kumar; L Groop; C B Wollheim; M D Nitert; C Ling
Journal:  Diabetologia       Date:  2010-11-23       Impact factor: 10.122

View more
  30 in total

1.  Chronic high glucose and pyruvate levels differentially affect mitochondrial bioenergetics and fuel-stimulated insulin secretion from clonal INS-1 832/13 cells.

Authors:  Isabel Göhring; Vladimir V Sharoyko; Siri Malmgren; Lotta E Andersson; Peter Spégel; David G Nicholls; Hindrik Mulder
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

2.  Temporal Proteomic Analysis of Pancreatic β-Cells in Response to Lipotoxicity and Glucolipotoxicity.

Authors:  Zonghong Li; Hongyang Liu; Zhangjing Niu; Wen Zhong; Miaomiao Xue; Jifeng Wang; Fuquan Yang; Yue Zhou; Yifa Zhou; Tao Xu; Junjie Hou
Journal:  Mol Cell Proteomics       Date:  2018-08-06       Impact factor: 5.911

Review 3.  Translational implications of the β-cell epigenome in diabetes mellitus.

Authors:  Justin S Johnson; Carmella Evans-Molina
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

4.  Real time analysis of metabolic profile in ex vivo mouse intestinal crypt organoid cultures.

Authors:  Tuba Bas; Leonard H Augenlicht
Journal:  J Vis Exp       Date:  2014-11-03       Impact factor: 1.355

5.  β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.

Authors:  Philippe A Halban; Kenneth S Polonsky; Donald W Bowden; Meredith A Hawkins; Charlotte Ling; Kieren J Mather; Alvin C Powers; Christopher J Rhodes; Lori Sussel; Gordon C Weir
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

Review 6.  Dietary Fat and the Genetic Risk of Type 2 Diabetes.

Authors:  Germán D Carrasquilla; Hermina Jakupović; Tuomas O Kilpeläinen
Journal:  Curr Diab Rep       Date:  2019-11-04       Impact factor: 4.810

7.  Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice.

Authors:  Takao Nammo; Haruhide Udagawa; Nobuaki Funahashi; Miho Kawaguchi; Takashi Uebanso; Masaki Hiramoto; Wataru Nishimura; Kazuki Yasuda
Journal:  Diabetologia       Date:  2018-10-03       Impact factor: 10.122

Review 8.  Lipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?

Authors:  Rohit B Sharma; Laura C Alonso
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

9.  The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice.

Authors:  Amit Kumar; Joseph Shiloach; Michael J Betenbaugh; Emily J Gallagher
Journal:  Nutr Metab (Lond)       Date:  2015-03-08       Impact factor: 4.169

10.  Characterization of stimulus-secretion coupling in the human pancreatic EndoC-βH1 beta cell line.

Authors:  Lotta E Andersson; Bérengère Valtat; Annika Bagge; Vladimir V Sharoyko; David G Nicholls; Philippe Ravassard; Raphael Scharfmann; Peter Spégel; Hindrik Mulder
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.